A total of 64 patients with cervical spondylotic myelopathy (CSM) were assessed in this study. Forty-two patients underwent selective expansive open-door laminoplasty (ELAP). Twenty-two patients who underwent conventional C3-7 ELAP served as controls. There were no significant differences in recovery rate of JOA scores, C2-C7 angle or cervical range of motion between two groups. Incidence of axial symptoms and segmental motor paralysis in selective ELAP was significantly lower than those in the C3-7 ELAP. Size of anterior compression mass, postoperative spinal cord positions and decompression conditions were evaluated using preoperative or postoperative MRI in 50 of 64 patients. There was a positive correlation between number of expanded laminae and maximum anterior spaces of spinal cord. Incomplete decompression was developed in three of 37 patients in selective ELAP and in two of 13 patients in C3-7ELAP. Mean size of anterior compression mass at incomplete decompression levels was significantly greater than that at complete decompression levels. Since, there was less posterior movement of the spinal cord in selective ELAP than that in C3-7ELAP, minute concerns about size of anterior compression mass is necessary to decide the number of expanded laminae. Overall, selective ELAP was less invasive and useful in reducing axial symptoms and segmental motor paralysis. This new surgical strategy was effective in improving the surgical outcomes of CSM, and short-term results were satisfactory.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2140119PMC
http://dx.doi.org/10.1007/s00586-007-0428-5DOI Listing

Publication Analysis

Top Keywords

selective elap
16
size anterior
12
anterior compression
12
compression mass
12
spinal cord
12
patients underwent
8
c3-7 elap
8
axial symptoms
8
symptoms segmental
8
segmental motor
8

Similar Publications

Article Synopsis
  • The study investigates the effectiveness of expansive open-door laminoplasty (ELAP) for treating multilevel cervical spondylotic myelopathy (CSM) in Chinese patients, focusing on short-term prognostic factors.
  • The research involved 98 patients who underwent ELAP, measuring outcomes like pain and functional improvement one year post-surgery through various clinical scales and imaging analyses.
  • Results showed significant improvements in both clinical scores and imaging indicators after surgery, along with age, duration of disease, and pre-operative scores identified as key factors influencing recovery.
View Article and Find Full Text PDF

Background: The K-line in the neck-flexed position (FK-line) on radiography reflects dynamic factors and cervical alignment. Although the FK-line has been reported to affect the neurological recovery after muscle-preserving selective laminectomy for cervical spondylotic myelopathy (CSM), its influence on surgical outcomes after expansive open-door laminoplasty (ELAP) has not been investigated.

Methods: We reviewed the surgical outcomes in 81 patients with multilevel CSM who underwent C4-C6 ELAP combined with C3 and C7 partial laminectomy using a laminoplasty plate and were followed up for at least 2 years.

View Article and Find Full Text PDF

Background: Granulocyte colony-stimulating factor (G-CSF) expressed in engineered Escherichia coli (E. coli) as a recombinant protein is utilized as an adjunct to chemotherapy for improving neutropenia. Recombinant proteins overexpression may lead to the creation of inclusion bodies whose recovery is a tedious and costly process.

View Article and Find Full Text PDF

Losartan is widely used in clinics to treat cardiovascular related diseases by selectively blocking the angiotensin II type 1 receptors (ATRs), which regulate the renin-angiotensin system (RAS). Therefore, monitoring the physiological and pathological biodistribution of ATR using positron emission tomography (PET) might be a valuable tool to assess the functionality of RAS. Herein, we describe the synthesis and characterization of two novel losartan derivatives PET tracers, [F]fluoroethyl-losartan ([F]FEtLos) and [F]ammoniomethyltrifluoroborate-losartan ([F]AMBFLos).

View Article and Find Full Text PDF

Background: Operative mortality after left ventricular assist device (LVAD) implantation is heavily influenced by patient selection and the technical difficulty of surgery. However, how we treat our patients and LVAD setting may affect the patient outcome beyond this period. We postulated that the presence of echocardiographic variables 1 month after surgery suggesting appropriate degree of LV unloading and an adequate forward flow would be important in determining clinical outcomes after the initial successful LVAD implantation.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!